Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$432M |
| 3 |
Abbott
ABT
|
+$420M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$472M |
| 2 |
Bank of America
BAC
|
+$426M |
| 3 |
TE Connectivity
TEL
|
+$399M |
| 4 |
Atlassian
TEAM
|
+$364M |
| 5 |
Goldman Sachs
GS
|
+$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAT
1976
American Assets Trust
AAT
$1.27B
| $511K | ﹤0.01% |
22,704
-31
| -0.1% | -$698 |
|
1977
National Beverage
FIZZ
$3.72B
| $511K | ﹤0.01% |
10,286
-18
| -0.2% | -$894 |
|
1978
Caleres
CAL
$528M
| $507K | ﹤0.01% |
16,507
-30
| -0.2% | -$921 |
|
1979
Tilray
TLRY
$1.23B
| $506K | ﹤0.01% |
219,391
| – | – |
|
|
NTST
1980
NETSTREIT Corp
NTST
$1.72B
| $506K | ﹤0.01% |
28,332
-44
| -0.2% | -$785 |
|
1981
Protagonist Therapeutics
PTGX
$3.5B
| $499K | ﹤0.01% |
21,734
-41
| -0.2% | -$941 |
|
1982
Manhattan Associates
MANH
$13.3B
| $498K | ﹤0.01% |
2,314
-48
| -2% | -$10.3K |
|
1983
Kaiser Aluminum
KALU
$1.24B
| $497K | ﹤0.01% |
6,973
-13
| -0.2% | -$926 |
|
1984
VSE Corp
VSEC
$3.46B
| $496K | ﹤0.01% |
7,681
-2,422
| -24% | -$157K |
|
|
FBRT
1985
Franklin BSP Realty Trust
FBRT
$959M
| $494K | ﹤0.01% |
36,537
-62
| -0.2% | -$838 |
|
1986
Weis Markets
WMK
$1.76B
| $492K | ﹤0.01% |
7,702
-13
| -0.2% | -$831 |
|
|
BVH
1987
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $492K | ﹤0.01% |
6,547
-8
| -0.1% | -$601 |
|
|
UMH
1988
UMH Properties
UMH
$1.29B
| $492K | ﹤0.01% |
32,114
-38
| -0.1% | -$582 |
|
1989
CyberArk
CYBR
$23.6B
| $491K | ﹤0.01% |
2,239
| – | – |
|
|
PGRE
1990
Paramount Group
PGRE
$1.65B
| $489K | ﹤0.01% |
94,540
-211
| -0.2% | -$1.09K |
|
1991
Employers Holdings
EIG
$997M
| $488K | ﹤0.01% |
12,371
-22
| -0.2% | -$868 |
|
1992
PRA Group
PRAA
$672M
| $487K | ﹤0.01% |
18,579
-32
| -0.2% | -$839 |
|
1993
Jamf
JAMF
$1.27B
| $487K | ﹤0.01% |
26,937
-34
| -0.1% | -$614 |
|
1994
Aspen Aerogels
ASPN
$557M
| $486K | ﹤0.01% |
30,805
-54
| -0.2% | -$852 |
|
1995
Comstock Resources
CRK
$4.53B
| $486K | ﹤0.01% |
54,831
-331
| -0.6% | -$2.93K |
|
1996
Columbus McKinnon
CMCO
$428M
| $485K | ﹤0.01% |
12,428
-22
| -0.2% | -$859 |
|
1997
Kymera Therapeutics
KYMR
$3.09B
| $485K | ﹤0.01% |
19,056
-35
| -0.2% | -$891 |
|
1998
DraftKings
DKNG
$23B
| $484K | ﹤0.01% |
13,718
-295
| -2% | -$10.4K |
|
1999
LeMaitre Vascular
LMAT
$2.2B
| $483K | ﹤0.01% |
8,512
-16
| -0.2% | -$909 |
|
|
MFA
2000
MFA Financial
MFA
$1.06B
| $483K | ﹤0.01% |
42,817
-77
| -0.2% | -$868 |
|